Opportunity
DIBBS #SPE2DP-26-T-4073
DLA Procurement of Novartis Artemether-Lumefantrine Tablets for Malaria Treatment
Posted
July 13, 2026
Respond By
July 20, 2026
Identifier
SPE2DP-26-T-4073
NAICS
424210
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharmacy FSA is seeking to procure Artemether-Lumefantrine Tablets for malaria treatment. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharmacy FSA - Buyer: Vanesa M Carbo Acevedo - OEM Highlight: - Novartis Pharmaceuticals Corporation is the sole approved manufacturer - Products Requested: - Artemether-Lumefantrine Tablets (NSN 6505-01-573-6500) - 26 bottles, each with 24 tablets - Each tablet: 20 mg Artemether, 120 mg Lumefantrine - Part numbers: COARTEM, NDC00078-0568-45 - Notable Requirements: - Minimum 21 months shelf life upon receipt - Must comply with FDA regulations and DLA packaging standards - Delivery required within 5 days of award to Fort Bragg, NC - Fast award process - No additional technical documents or alternative OEMs are referenced
Description
LUMEFANTRINE ARTEME (QTY: 26, NSN: 6505-01-573-6500, Purchase Request: 7017435974) Approved Sources: - CAGE: 04520, Part No: COARTEM, Company: NOVARTIS PHARMACEUTICALS CORPORATIO - CAGE: 04520, Part No: NDC00078-0568-45, Company: NOVARTIS PHARMACEUTICALS CORPORATIO